AA

Anjali Ajit Deval

Active Director Designated Partner DIN 06701001
DIN 06701001 First appointment Apr 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Apr 2013
Shareholding value •••• Premium profile

About Anjali Ajit Deval

Data last updated:

Anjali Ajit Deval is a Designated Partner at Nivian Pharma Llp (since 2024), Director at Spring Life Sciences Private Limited (since 2017) and Director at Skinnovate Technologies Private Limited (since 2025), and holds 3 more current directorships. The companies operate in Pharma, Healthcare and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹17.12 Cr; the largest is Nivian Pharma Llp at ₹14.80 Cr (FY 2023). Earlier, Anjali Ajit Deval was a Director at Spring Ivf And Fertility Private Limited (2013–2017).

DIN 06701001
Primary Designation Designated Partner
Industry Pharma
First Appointment 23 Apr 2013
Oldest Company Age 9 yrs
Largest company Nivian Pharma Llp · ₹14.80 Cr (FY 2023)
Combined revenue ₹17.12 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Feb 20242018₹14.80 Cr (FY 2023)Active
Spring Life Sciences Private Limited U85200MH2017PTC294270
Director12 Sep 20172017₹2.32 Cr (FY 2024)Active
Director17 Apr 20252025Active
Nivian Life Sciences Private Limited U21001MH2024PTC421643
Director18 Mar 20242024Active
Designated Partner17 Aug 20222022Active
Designated Partner18 Aug 20212018Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Apr 20132013Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Clara Ventures Llp
Nivian Pharma Llp
Spring Life Sciences Private Limited
Anjali & Ananya Fertility Llp
Premium access

Shareholding and investment profile for Anjali Ajit Deval

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjali Ajit Deval

Anjali Ajit Deval currently holds 6 directorships: Nivian Pharma Llp (Designated Partner, since 27 Feb 2024, revenue ₹14.80 Cr (FY 2023)); Spring Life Sciences Private Limited (Director, since 12 Sep 2017, revenue ₹2.32 Cr (FY 2024)); Skinnovate Technologies Private Limited (Director, since 17 Apr 2025); Nivian Life Sciences Private Limited (Director, since 18 Mar 2024); Anjali & Ananya Fertility Llp (Designated Partner, since 17 Aug 2022); and 1 more.

Anjali Ajit Deval was first appointed on 23 Apr 2013 as Director at Spring Ivf And Fertility Private Limited. The most recent appointment on record is 17 Apr 2025 at Skinnovate Technologies Private Limited.

The 2 current companies of Anjali Ajit Deval that report revenue have a combined latest revenue of ₹17.12 Cr: Nivian Pharma Llp ₹14.80 Cr (FY 2023); Spring Life Sciences Private Limited ₹2.32 Cr (FY 2024).

Anjali Ajit Deval held 1 earlier board appointment: Spring Ivf And Fertility Private Limited (Director, 23 Apr 2013 to 30 May 2017).

The current boards of Anjali Ajit Deval's companies include Nilesh Namdev Auti (Nivian Pharma Llp), Ajit Dattatraya Deval (Spring Life Sciences Private Limited), Beena Bihari Choudhary (Skinnovate Technologies Private Limited), Roshan Shiva Thapa (Skinnovate Technologies Private Limited), Kadayam Ramanathan Bharat (Nivian Life Sciences Private Limited), Mehernosh Framroze Daruwalla (Nivian Life Sciences Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available